Korean J Med.
2002 Feb;62(2):204-208.
A case of anaphylaxis to human recombinant insulin treated by desensitization
- Affiliations
-
- 1Department of Internal Medicine, Inha University College of Medicine, Inchon, Korea.
- 2Department of Internal Medicine, Ulsan University College of Medicine, Ulsan, Korea. choisw@uuh.ulsan.kr.
Abstract
- Allergic reaction to insulin is mediated by several mechanisms; differences in amino acid sequence of animal and human insulin, altered tertiary structure of insulin and the presence of non-insulin protein contaminants or pharmaceutical additives. Anaphylactic reactions to insulin only occur in 0.1 to 2% of patients who stopped insulin therapy and have then resumed treatment. We report a diabetic patient who suffered severe anaphylactic reactions to human recombinant insulin, successfully treated by desensitization. A 19-year-old man with type 1 diabetes receiving Insulatard HM(R) developed generalized urticaria and angioedema with progression to dyspnea, dizziness and syncope. Skin prick test to all kinds of human recombinant insulin products revealed immediate type hypersensitivity and the titer of insulin IgE was increased in serum. The desensitization trial with Velosulin HM(R) using modified desensitization method was performed. Six months after the desensitization he was taking Velosulin HM(R) as well as Insulatard HM(R) without any evidence of systemic allergic reactions.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Successful Desensitization of A Case of Anaphylaxis to Insulin
- A Case of Desensitization for Hemophilia B Inhibitor Patient with Anaphylaxis to FIX Concentrates
- Allergic reaction to recombinant human insulin
- A Case of Human Insulin Allergy Induced by Rapid Acting Human Recombinant Insulin, Humulin-R
- Maintenance of Insulin Therapy by Desensitization in Insulin Allergy Patient
